BRADLEY PECHTER: Open Payments
NPI 1093922346 · MELROSE PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,539 in 76 payments from 15 companies in 2025. Trend: 2023 $829 · 2024 $973 · 2025 $1,539
Food & beverage: $1,539
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 11 | $228 |
| Janssen Pharmaceuticals, Inc | 8 | $177 |
| Lundbeck LLC | 9 | $161 |
| Collegium Pharmaceutical, Inc. | 9 | $156 |
| Tris Pharma Inc | 8 | $154 |
| Corium, LLC | 4 | $117 |
| Vertical Pharmaceuticals, LLC | 6 | $105 |
| ABBVIE INC. | 4 | $88 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
Products named: Qelbree, REXULTI, SPRAVATO, Jornay PM, Dyanavel XR, Azstarys, Relexxii, VRAYLAR.
Industry payments across IL — which companies pay providers there.
